King Pharmaceuticals Inc. (KG) reported third-quarter net income of $42.49 million or $0.17 per share compared to $82.47 million or $0.34 per share last year.
Net income excluding non-GAAP items was $71.32 million or $0.29 per share compared $95.43 million per $0.39 share prior year.
On average, 15 analysts polled by Thomson Reuters expected the company to report profit of $0.27 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenues increased to $463.35 million from $388.44 million last year. Analysts expected revenue of $444.98 million for the quarter.
For comments and feedback: editorial@rttnews.com